Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 157

1.

L1CAM Predicts Adverse Outcomes in Patients with Endometrial Cancer Undergoing Full Lymphadenectomy and Adjuvant Chemotherapy.

Asano H, Hatanaka KC, Matsuoka R, Dong P, Mitamura T, Konno Y, Kato T, Kobayashi N, Ihira K, Nozaki A, Oku A, Matsuno Y, Hatanaka Y, Watari H.

Ann Surg Oncol. 2019 Dec 2. doi: 10.1245/s10434-019-08103-2. [Epub ahead of print]

PMID:
31792716
2.

High-risk Human Papillomavirus Testing in Young Japanese Women with Atypical Squamous Cells of Undetermined Significance.

Mitamura T, Konno Y, Kikawa S, Iwaki Y, Iwaki K, Tanuma F, Kataoka S.

J Cytol. 2019 Jul-Sep;36(3):180-183. doi: 10.4103/JOC.JOC_148_17.

3.

A randomized controlled trial of a bidirectional cultural adaptation of cognitive behavior therapy for children and adolescents with anxiety disorders.

Ishikawa SI, Kikuta K, Sakai M, Mitamura T, Motomura N, Hudson JL.

Behav Res Ther. 2019 Sep;120:103432. doi: 10.1016/j.brat.2019.103432. Epub 2019 Jun 20.

PMID:
31299461
4.

Molecular-targeted therapies and precision medicine for endometrial cancer.

Mitamura T, Dong P, Ihira K, Kudo M, Watari H.

Jpn J Clin Oncol. 2019 Feb 1;49(2):108-120. doi: 10.1093/jjco/hyy159. Review.

PMID:
30423148
5.

PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer.

Hisamatsu T, McGuire M, Wu SY, Rupaimoole R, Pradeep S, Bayraktar E, Noh K, Hu W, Hansen JM, Lyons Y, Gharpure KM, Nagaraja AS, Mangala LS, Mitamura T, Rodriguez-Aguayo C, Eun YG, Rose J, Bartholomeusz G, Ivan C, Lee JS, Matsuo K, Frumovitz M, Wong KK, Lopez-Berestein G, Sood AK.

Mol Cancer Ther. 2019 Jan;18(1):162-172. doi: 10.1158/1535-7163.MCT-17-1050. Epub 2018 Oct 10.

6.

miR-363 confers taxane resistance in ovarian cancer by targeting the Hippo pathway member, LATS2.

Mohamed Z, Hassan MK, Okasha S, Mitamura T, Keshk S, Konno Y, Kato T, El-Khamisy SF, Ohba Y, Watari H.

Oncotarget. 2018 Jul 10;9(53):30053-30065. doi: 10.18632/oncotarget.25698. eCollection 2018 Jul 10.

7.

The Anti-tumor Effect of Cabozantinib on Ovarian Clear Cell Carcinoma In Vitro and In Vivo.

Nakatani M, Watari H, Mitamura T, Wang L, Hatanaka Y, Hatanaka KC, Honda K, Nomura T, Nishihara H, Tanaka S, Sakuragi N.

Anticancer Res. 2017 Nov;37(11):6125-6132.

PMID:
29061793
8.

Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP).

Mitamura T, Pradeep S, McGuire M, Wu SY, Ma S, Hatakeyama H, Lyons YA, Hisamatsu T, Noh K, Villar-Prados A, Chen X, Ivan C, Rodriguez-Aguayo C, Hu W, Lopez-Berestein G, Coleman RL, Sood AK.

Oncogene. 2018 Feb 8;37(6):722-731. doi: 10.1038/onc.2017.348. Epub 2017 Oct 23.

9.

Role of ADP receptors on platelets in the growth of ovarian cancer.

Cho MS, Noh K, Haemmerle M, Li D, Park H, Hu Q, Hisamatsu T, Mitamura T, Mak SLC, Kunapuli S, Ma Q, Sood AK, Afshar-Kharghan V.

Blood. 2017 Sep 7;130(10):1235-1242. doi: 10.1182/blood-2017-02-769893. Epub 2017 Jul 5.

10.

Control of Pseudomonas mastitis on a large dairy farm by using slightly acidic electrolyzed water.

Kawai K, Shinozuka Y, Uchida I, Hirose K, Mitamura T, Watanabe A, Kuruhara K, Yuasa R, Sato R, Onda K, Nagahata H.

Anim Sci J. 2017 Oct;88(10):1601-1605. doi: 10.1111/asj.12815. Epub 2017 May 18.

PMID:
28516730
11.

Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers.

Hatakeyama H, Wu SY, Lyons YA, Pradeep S, Wang W, Huang Q, Court KA, Liu T, Nie S, Rodriguez-Aguayo C, Shen F, Huang Y, Hisamatsu T, Mitamura T, Jennings N, Shim J, Dorniak PL, Mangala LS, Petrillo M, Petyuk VA, Schepmoes AA, Shukla AK, Torres-Lugo M, Lee JS, Rodland KD, Fagotti A, Lopez-Berestein G, Li C, Sood AK.

Cell Rep. 2016 Nov 1;17(6):1621-1631. doi: 10.1016/j.celrep.2016.10.020.

12.

Role of Increased n-acetylaspartate Levels in Cancer.

Zand B, Previs RA, Zacharias NM, Rupaimoole R, Mitamura T, Nagaraja AS, Guindani M, Dalton HJ, Yang L, Baddour J, Achreja A, Hu W, Pecot CV, Ivan C, Wu SY, McCullough CR, Gharpure KM, Shoshan E, Pradeep S, Mangala LS, Rodriguez-Aguayo C, Wang Y, Nick AM, Davies MA, Armaiz-Pena G, Liu J, Lutgendorf SK, Baggerly KA, Eli MB, Lopez-Berestein G, Nagrath D, Bhattacharya PK, Sood AK.

J Natl Cancer Inst. 2016 Jan 26;108(6):djv426. doi: 10.1093/jnci/djv426.

13.

Prediction of anti-angiogenesis escape.

Mitamura T, Gourley C, Sood AK.

Gynecol Oncol. 2016 Apr;141(1):80-5. doi: 10.1016/j.ygyno.2015.12.033. Epub 2015 Dec 31. Review.

14.

Human papillomavirus type 16 sequence variation in concurrent vulvar and penile carcinoma in a married couple.

Mitamura T, Watari H, Yamashiro K, Kato T, Hosaka M, Shimada C, Fukumoto S, Noshiro K, Sasaki T, Sakuragi N.

Sex Transm Dis. 2015 Jun;42(6):342-3. doi: 10.1097/OLQ.0000000000000274.

PMID:
25970313
15.

P18/Stathmin1 is regulated by miR-31 in ovarian cancer in response to taxane.

Hassan MK, Watari H, Mitamura T, Mohamed Z, El-Khamisy SF, Ohba Y, Sakuragi N.

Oncoscience. 2015 Mar 23;2(3):294-308. eCollection 2015.

16.

MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells.

Konno Y, Dong P, Xiong Y, Suzuki F, Lu J, Cai M, Watari H, Mitamura T, Hosaka M, Hanley SJ, Kudo M, Sakuragi N.

Oncotarget. 2014 Aug 15;5(15):6049-62.

17.

Lymphadenectomy can be omitted for low-risk endometrial cancer based on preoperative assessments.

Mitamura T, Watari H, Todo Y, Kato T, Konno Y, Hosaka M, Sakuragi N.

J Gynecol Oncol. 2014 Oct;25(4):301-5. doi: 10.3802/jgo.2014.25.4.301. Epub 2014 Jun 18.

18.

microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway.

Mitamura T, Watari H, Wang L, Kanno H, Kitagawa M, Hassan MK, Kimura T, Tanino M, Nishihara H, Tanaka S, Sakuragi N.

Mol Cancer. 2014 Apr 29;13:97. doi: 10.1186/1476-4598-13-97.

19.

Distribution of lymph node metastasis sites in endometrial cancer undergoing systematic pelvic and para-aortic lymphadenectomy: a proposal of optimal lymphadenectomy for future clinical trials.

Odagiri T, Watari H, Kato T, Mitamura T, Hosaka M, Sudo S, Takeda M, Kobayashi N, Dong P, Todo Y, Kudo M, Sakuragi N.

Ann Surg Oncol. 2014 Aug;21(8):2755-61. doi: 10.1245/s10434-014-3663-0. Epub 2014 Apr 5.

PMID:
24705578
20.

Multivariate prognostic analysis of adenocarcinoma of the uterine cervix treated with radical hysterectomy and systematic lymphadenectomy.

Kato T, Watari H, Takeda M, Hosaka M, Mitamura T, Kobayashi N, Sudo S, Kaneuchi M, Kudo M, Sakuragi N.

J Gynecol Oncol. 2013 Jul;24(3):222-8. doi: 10.3802/jgo.2013.24.3.222. Epub 2013 Jul 4.

21.

Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET.

Mitamura T, Watari H, Wang L, Kanno H, Hassan MK, Miyazaki M, Katoh Y, Kimura T, Tanino M, Nishihara H, Tanaka S, Sakuragi N.

Oncogenesis. 2013 Mar 25;2:e40. doi: 10.1038/oncsis.2013.3.

22.

A low-risk group for lymph node metastasis is accurately identified by Korean gynecologic oncology group criteria in two Japanese cohorts with endometrial cancer.

Kang S, Todo Y, Odagiri T, Mitamura T, Watari H, Kim JW, Nam JH, Sakuragi N.

Gynecol Oncol. 2013 Apr;129(1):33-7. doi: 10.1016/j.ygyno.2013.01.005. Epub 2013 Jan 13.

PMID:
23321063
23.

New revised FIGO 2008 staging system for endometrial cancer produces better discrimination in survival compared with the 1988 staging system.

Kato T, Watari H, Endo D, Mitamura T, Odagiri T, Konno Y, Hosaka M, Kobayashi N, Todo Y, Sudo S, Takeda M, Dong P, Kaneuchi M, Kudo M, Sakuragi N.

J Surg Oncol. 2012 Dec;106(8):938-41. doi: 10.1002/jso.23203. Epub 2012 Jun 27.

PMID:
22740340
24.

Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting clusterin improves response to paclitaxel.

Hassan MK, Watari H, Han Y, Mitamura T, Hosaka M, Wang L, Tanaka S, Sakuragi N.

J Exp Clin Cancer Res. 2011 Dec 20;30:113. doi: 10.1186/1756-9966-30-113.

25.

Clinical efficacy of paclitaxel/cisplatin as an adjuvant chemotherapy for patients with cervical cancer who underwent radical hysterectomy and systematic lymphadenectomy.

Hosaka M, Watari H, Kato T, Odagiri T, Konno Y, Endo D, Mitamura T, Kikawa S, Suzuki Y, Sakuragi N.

J Surg Oncol. 2012 May;105(6):612-6. doi: 10.1002/jso.22136. Epub 2011 Nov 7.

PMID:
22065519
27.

Multivariate survival analysis of the patients with recurrent endometrial cancer.

Odagiri T, Watari H, Hosaka M, Mitamura T, Konno Y, Kato T, Kobayashi N, Sudo S, Takeda M, Kaneuchi M, Sakuragi N.

J Gynecol Oncol. 2011 Mar 31;22(1):3-8. doi: 10.3802/jgo.2011.22.1.3.

28.

Photochemical intramolecular cyclization of o-alkynylaryl isocyanides with organic dichalcogenides leading to 2,4-bischalcogenated quinolines.

Mitamura T, Iwata K, Nomoto A, Ogawa A.

Org Biomol Chem. 2011 May 21;9(10):3768-75. doi: 10.1039/c0ob01168a. Epub 2011 Apr 11.

PMID:
21483966
29.

Photoinduced intramolecular cyclization of o-ethenylaryl isocyanides with organic disulfides mediated by diphenyl ditelluride.

Mitamura T, Iwata K, Ogawa A.

J Org Chem. 2011 May 20;76(10):3880-7. doi: 10.1021/jo200299d. Epub 2011 Apr 18.

PMID:
21462977
30.

Inhibitory potency of tacrolimus ointment on skin tumor induction in a mouse model of an initiation-promotion skin tumor.

Mitamura T, Doi Y, Kawabe M, Lilja H, Motomura M, Oishi Y, Yoshizawa K, Seki J.

J Dermatol. 2011 Jun;38(6):562-70. doi: 10.1111/j.1346-8138.2010.01046.x. Epub 2010 Oct 6.

PMID:
21352294
31.

Synthesis of 2,4-diiodoquinolines via the photochemical cyclization of o-alkynylaryl isocyanides with iodine.

Mitamura T, Ogawa A.

J Org Chem. 2011 Feb 18;76(4):1163-6. doi: 10.1021/jo1021772. Epub 2011 Jan 18.

PMID:
21244063
32.

Survival and prognosticators of node-positive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.

Hosaka M, Watari H, Mitamura T, Konno Y, Odagiri T, Kato T, Takeda M, Sakuragi N.

Int J Clin Oncol. 2011 Feb;16(1):33-8. doi: 10.1007/s10147-010-0123-0. Epub 2010 Sep 15.

PMID:
20842404
33.

Clusterin expression inversely correlates with chemosensitivity and predicts poor survival in patients with locally advanced cervical cancer treated with cisplatin-based neoadjuvant chemotherapy and radical hysterectomy.

Watari H, Kanuma T, Ohta Y, Hassan MK, Mitamura T, Hosaka M, Minegishi T, Sakuragi N.

Pathol Oncol Res. 2010 Sep;16(3):345-52. doi: 10.1007/s12253-009-9235-0. Epub 2010 Jan 8.

PMID:
20058210
34.

Survival and failure pattern of patients with endometrial cancer after extensive surgery including systematic pelvic and para-aortic lymphadenectomy followed by adjuvant chemotherapy.

Watari H, Mitamura T, Moriwaki M, Hosaka M, Ohba Y, Sudo S, Todo Y, Takeda M, Ebina Y, Sakuragi N.

Int J Gynecol Cancer. 2009 Dec;19(9):1585-90. doi: 10.1111/IGC.0b013e3181a833cc.

PMID:
19955942
35.
36.

A 14-year-old female patient with FIGO stage IB endometrial carcinoma: a case report.

Mitamura T, Watari H, Todo Y, Koshida T, Sakuragi N.

Int J Gynecol Cancer. 2009 Jul;19(5):896-7. doi: 10.1111/IGC.0b013e3181a8342a.

PMID:
19574781
37.
38.

Copper(0)-induced deselenative insertion of N,N-disubstituted selenoamides into acetylenic C-H bond leading to propargylamines.

Mitamura T, Ogawa A.

Org Lett. 2009 May 21;11(10):2045-8. doi: 10.1021/ol9001976.

PMID:
19419207
39.

Intrathoracic injection of paclitaxel for a patient with stage IV serous ovarian cancer: a case report.

Mitamura T, Hosaka M, Takeda M, Watari H, Sakuragi N.

Cancer Chemother Pharmacol. 2009 Jun;64(1):169-70. doi: 10.1007/s00280-009-0951-7. Epub 2009 Feb 18.

PMID:
19224213
40.

Weekly paclitaxel/5-fluorouracil followed by platinum retreatment for patients with recurrent ovarian cancer: a single institution experience.

Watari H, Hosaka M, Mitamura T, Moriwaki M, Ohba Y, Todo Y, Takeda M, Ebina Y, Sakuragi N.

Eur J Gynaecol Oncol. 2008;29(6):573-7.

PMID:
19115681
41.

Effect of pharmacokinetic profile on the pancreatic toxicity and efficacy of tacrolimus in rats.

Mitamura T, Yamada A, Hanaoka K, Asano M, Niwa T, Seki J.

J Toxicol Sci. 2008 Dec;33(5):575-84.

42.

Oleic acid is indispensable for intraerythrocytic proliferation of Plasmodium falciparum.

Mi-Ichi F, Kano S, Mitamura T.

Parasitology. 2007 Nov;134(Pt 12):1671-7. Epub 2007 Jul 5.

PMID:
17610764
43.

Association of the diplotype configuration at the N-acetyltransferase 2 gene with adverse events with co-trimoxazole in Japanese patients with systemic lupus erythematosus.

Soejima M, Sugiura T, Kawaguchi Y, Kawamoto M, Katsumata Y, Takagi K, Nakajima A, Mitamura T, Mimori A, Hara M, Kamatani N.

Arthritis Res Ther. 2007;9(2):R23.

44.

Intraerythrocytic Plasmodium falciparum utilize a broad range of serum-derived fatty acids with limited modification for their growth.

Mi-Ichi F, Kita K, Mitamura T.

Parasitology. 2006 Oct;133(Pt 4):399-410. Epub 2006 Jun 19.

PMID:
16780611
45.

High-temperature and high-pressure in situ SCC device for synchrotron radiation diffraction experiments and application using an austenitic stainless steel.

Yamamoto A, Nakahigashi S, Terasawa M, Mitamura T, Akiniwa Y, Yamada T, Liu L, Shobu T, Tsubakino H.

J Synchrotron Radiat. 2006 Jan;13(Pt 1):14-8. Epub 2005 Dec 22.

PMID:
16371704
46.

Proteolipid of vacuolar H(+)-ATPase of Plasmodium falciparum: cDNA cloning, gene organization and complementation of a yeast null mutant.

Yatsushiro S, Taniguchi S, Mitamura T, Omote H, Moriyama Y.

Biochim Biophys Acta. 2005 Nov 30;1717(2):89-96. Epub 2005 Sep 15.

47.

Plasmodium falciparum serine-repeat antigen (SERA) forms a homodimer through disulfide bond.

Sato D, Li J, Mitamura T, Horii T.

Parasitol Int. 2005 Dec;54(4):261-5.

PMID:
16048741
48.

Atomic imaging in EBCO superconductor films by an X-ray holography system using a toroidally bent graphite analyzer.

Sekioka T, Hayashi K, Matsubara E, Takahashi Y, Hayashi T, Terasawa M, Mitamura T, Iwase A, Michikami O.

J Synchrotron Radiat. 2005 Jul;12(Pt 4):530-3. Epub 2005 Jun 15.

PMID:
15968134
49.

Outcomes of patients with acute leukaemia who relapsed after reduced-intensity stem cell transplantation from HLA-identical or one antigen-mismatched related donors.

Kobayashi K, Kami M, Murashige N, Kusumi E, Kishi Y, Hamaki T, Hori A, Matsumura T, Yuji K, Masuo S, Mori S, Miyakoshi S, Tanosaki R, Mitamura T, Takaue Y, Taniguchi S; Tokyo SCT Consortium Institution.

Br J Haematol. 2005 Jun;129(6):795-802.

PMID:
15953007
50.

Graft-versus-host disease of the kidney after rapid tapering of cyclosporin following reduced intensity hematopoietic stem cell transplantation.

Homma CI, Kami M, Masuo S, Sakiyama M, Kojima R, Hori A, Kusumi E, Katori H, Takeuchi K, Kishi Y, Murashige N, Kim SW, Takaue Y, Mitamura T.

Bone Marrow Transplant. 2005 May;35(9):929-30. No abstract available.

PMID:
15765112

Supplemental Content

Loading ...
Support Center